ETRA

Conviction 0HealthcareScan · Fri, Sep 25, 2026

Electra Therapeutics, Inc. (ETRA) closed at $11.54 (-2.37%) on Sep 25, 2026. -17.1% from its 52-week high, -12.9% year to date. Sector: Healthcare · Biotechnology.

ETRA$11.54-2.37%

ResistanceSupportVol 14Insider buy

Sep 18Sep 21Sep 22Sep 23Sep 24Sep 25

Electra Therapeutics, Inc.Biotechnology

Price11.54

Change-2.37%

Gap+7.78%

Rel volume0.35×

Avg volume1.37M

Avg $ vol17.95M

SMA 20—

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrend—

RSI (14)—

MACD hist—

MACD cross—

Stoch %K / %D— / —

ADX (14)—

+DI / −DI— / —

RSI divergence—

MACD divergence—

ATR %—

ADR %—

52w high13.92

52w low11.54

From 52w high-17.10%

Above 52w low+0.00%

New 52w highNo

SqueezeOff

Bollinger width—

%B—

Donchian pos—

Donchian high—

Donchian low—

AVWAP (52w high)13.65

vs AVWAP high-15.48%

AVWAP (52w low)11.86

vs AVWAP low-2.70%

OBV trend—

Chaikin MF (20)—

Today vs 20d0.35×

Avg vol (14d)—

Avg vol (20d)1.37M

Avg $ vol (20d)17.95M

Market cap—

RS Rating—

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank2.5

1 week-12.91%

1 month—

3 months—

6 months—

1 year—

YTD-12.91%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value—

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out—

Employees—

Listed—

Free float36.06M

Float %57.4%

Short interest—

Days to cover—

Short volume79.2%

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank2.5 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirm—

Congress activity

Disclosed STOCK Act trades in ETRA

All disclosures →

No recent disclosed trades by Congress in ETRA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ETRA · open-market 2 buys

Insider	Side	Shares	Value	Traded	Filed
ORBIMED ADVISORS LLC Director · Common Stock · 2026-09-21	Convert	2M	—	2026-09-21	2026-09-23
ORBIMED ADVISORS LLC Director · Common Stock · 2026-09-21	Convert	1.09M	—	2026-09-21	2026-09-23
ORBIMED ADVISORS LLC Director · Common Stock · 2026-09-21	Convert	1.7M	—	2026-09-21	2026-09-23
ORBIMED ADVISORS LLC Director · Common Stock · 2026-09-21	Buy	333.33K	$5.0M	2026-09-21	2026-09-23
ORBIMED ADVISORS LLC Director · Common Stock · 2026-09-21	Convert	758.28K	—	2026-09-21	2026-09-23
ORBIMED ADVISORS LLC Director · Common Stock · 2026-09-21	Buy	1M	$15M	2026-09-21	2026-09-23
ORBIMED ADVISORS LLC Director · Series A Convertible Preferred Stock · 2026-09-21	Convert	2M	—	2026-09-21	2026-09-23
ORBIMED ADVISORS LLC Director · Series B Convertible Preferred Stock · 2026-09-21	Convert	1.09M	—	2026-09-21	2026-09-23
ORBIMED ADVISORS LLC Director · Series C Convertible Preferred Stock · 2026-09-21	Convert	1.7M	—	2026-09-21	2026-09-23
ORBIMED ADVISORS LLC Director · Series C Convertible Preferred Stock · 2026-09-21	Convert	758.28K	—	2026-09-21	2026-09-23

SEC filings

EDGAR filings in ETRA · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

ETRA

Recent news

Get daily signals & real-time alerts.